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Abstract  
 
Background: Mountain ginseng (Panax ginseng Meyer), which belongs to Araliaceae family, grows naturally in the 
mountains of Korea. It is highly valued owing to its enhanced pharmacology effects such as immunostimulating, 
antioxidant, anti-cancer and antiaging activity. An alternative to accessing the sparse mountain ginseng therapy benefits is 
by tissue-cultured roots of mountain ginseng. The aim of this study is to evaluate the effect of water extract of cultured 
roots of mountain ginseng (CRMG) and specifically its major compound ginsenoside Re (Re) on melanin synthesis in α-
MSH-stimulated mouse melanoma B16BL6 cells (B16).  
Materials and Methods:  Cell cytotoxicity was evaluated trough a comparative study using normal human dermal 
fibroblast (HDF) and B16. Then, α-MSH-stimulated B16 cells were analyzed, using melanin and tyrosinase activity assay. 
Tyrosinase gene expression was evaluated trough reverse transcription polymerase chain reaction analysis and quantitative 
PCR analysis. Finally, an in silico docking study was performed. 
Results: The study demonstrated that CRMG and Re were non-toxic compounds and significantly reduced tyrosinase 
activity and melanin content in B16 cells. Re decreased the mRNA expression of tyrosinase and other melanin synthesis-
related genes in B16 cells. In addition, in silico docking studies showed that Re had stronger interaction with tyrosinase 
compared to control drug arbutin due to its higher binding affinity.  
Conclusion:  Taken together, our results suggest that CRMG and Re possess potential anti-melanogenic activities and may 
be used as antimelanogenic cosmeceutical agents. 
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List of abbreviations: CRMG: culture roots of mountain ginseng, Re: ginsenoside Re, α-MSH: alpha-Melanocyte-
stimulating hormone, B16: murine melanomaB16BL6 cells, HDF: human dermal fibroblast cells, TYR: tyrosinase, TRP-1: 
tyrosinase-related protein 1, TRP-2: tyrosinase–related protein 2, MITF: microphthalmia-associated transcription factor, 
DPPH: 2,2-Diphenyl-1-picrylhydrazyl, DMEM: dulbecco’s modified eagle medium high glucose pyruvate, FBS: fetal 
bovine serum, HPLC: high-performance liquid chromatography, ADMET: absorption, distribution, metabolism, excretion, 
and toxicity, PASS: Prediction of Activity Spectra for Substances, DMSO: dimethyl sulfoxide. 
 
Introduction 
 
Melanocytes are responsible for producing melanin in melanosomes tissues which determine skin and hair color 
(Su et al., 2013). Melanin acts as the primary protection factor of the skin from ultraviolet damage by absorbing ultraviolet 
sunlight and removing reactive oxygen species. However, excessive production of melanin can create severe skin ailments 
including patches on the skin, ephelis, and melasma (Briganti et al., 2003). Tyrosinase gene family, which is composed of 
tyrosinase (TYR), tyrosinase-related protein 1 (TRP-1) and tyrosinase–related protein 2 (TRP-2), has an essential function 
in regulating melanogenesis pathway. Furthermore, microphthalmia-associated transcription factor (MITF) is crucial for the 
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regulation of melanocyte proliferation, melanogenesis and major regulator of tyrosinase and the related enzymes 
transcriptions factors (Park et al., 2013).  One study demonstrated that utilization of cosmeceuticals with anti-tyrosinase 
compounds can result in lightening of skin (Kim and Uyama, 2005). Generally, commercially available skin whitening 
agents are associated with undesirable side effects such as local irritation, contact dermatitis, ochronosis, atrophy and skin 
cancer (Draelos, 2007). In lieu of conventional chemical-based whitening agents, special interest has been directed to non-
artificial, botanical products.  
The root of mountain ginseng (Panax ginseng Meyer) is well-known due to its enhanced pharmacological 
activities. However, its expensive price tag and scarcity have made it relatively inaccessible for potential users. Cultured 
roots from mountain ginseng tissue have emerged as alternatives for larger and cheaper production of ginseng roots.   
In recent years, scientific discoveries have been disseminated about the efficacy of ginseng extracts and saponins 
on skin. Previously published reports have demonstrated that saponins possess antimelanogenic activity (Kim, 2015). 
Ginsenoside F1, a derivative of ginsenoside Rg1, has been found to be effective as skin whitening agent by suppressing 
tyrosinase (Yoo et al., 2011). In vitro studies of ginsenoside Rb1, an aglycone of ginsenoside Rh4, and ethanol extract of 
ginseng seed have also been shown to have skin whitening effect though inhibition of tyrosinase activity and melanin 
content (Lim et al., 1999; Jeong et al., 2013; Wang et al., 2014). However, no study has been made to evaluate the anti-
melanogenic activities of aqueous CRMG extract and ginsenoside Re. The aim of this study is to evaluate CMRG and its 
major compound ginsenoside Re for their efficacy as natural whitening therapeutic agents. 
 
Materials and Methods  
 
Cultured roots of mountain ginseng and ginsenoside Re were acquired from the Ginseng Bank (Kyung Hee 
University, KO). Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine serum (FBS), and penicillin-streptomycin 
(PS) were purchased from GenDEPOT (TX, USA). 3-(4,5-dimethyl-thiazol-2yl)-2, 5-diphenyl tetrazolium bromide (MTT) 
was acquired from Life technologies (OR, USA). Arbutin and L-3,4-dihydroxyphenylalanin (L-DOPA) were acquired from 
Abcam (Cambridge, UK.). α-melanocyte-stimulating hormone (α-MSH) was obtained from Sigma (MO, USA). 
 
 Preparation of aqueous extract of cultured roots of mountain ginseng 
 
The CRMG extract was prepared as described previously (Oh et al., 2006) with minor modifications.  The CMGR 
roots (400 g) were washed with water, dried and ground into fine powder. Next, aqueous extract of CRMG roots was 
extracted by autoclaving with distilled water at 100 °C for 30 min. The resulting extract was centrifuged and the 
supernatant collected and freeze-dried.  The residue was diluted with distilled water and filtered using Whatman filter paper 
(0.45 µm) to obtain filtrate. The total filtrate was stored at -20 °C for further use.  
 
Analysis of ginseng saponins of cultured roots of mountain ginseng extract by HPLC 
  
The amount of the ginseng saponins in CRMG was determined by HPLC analysis as previously described by Jin et 
al. (2015). Briefly, HPLC was carried out using an Agilent 1260 system (CA, USA). Ginsenosides were resolved on a 
column C18 (Kinetex ID 2.6 µm, 50 mm × 4.6 mm), with H2O (solvent A) and acetonitrile (solvent B) at A: B ratios of 
83:17, 83:17, 71:29, 60:40, 30:70, 10:90, 10:90, 83:17, and 83:17, with run times of 0, 6, 9, 14, 17, 18.5, 22, 22.5, and 26 
min, respectively at a flow rate of 1.0 mL/min and detection wavelength of 203 nm. 
 
Cell culture  
 
Human dermal fibroblast (HDF) and B16 cell lines were purchased from Korean Cell Line Bank (SEL, KO). Cells 
were cultivated in DMEM media and complemented with 10 % FBS and 1 % PS at 37 °C, 95 % humidified air and 5 % 
CO2 conditions as previous described (Lee et al., 2007; Yoo et al., 2011). 
 
Cell viability assay 
  
The cytotoxic effect of CRMG and Re on HDF and B16 cells was measured by MTT assay. Both cell lines were 
seeded at a density of 1×10⁵ in 96 well plates and cultured for 24 h. At 90 % confluence, cells were treated with various 
concentrations of CRMG (1-1000 µg/mL) and Re (1-300 µM) for 72 h.  After 3 days of incubation, cells were treated with 
10 µL of MTT solution and incubated for a period of 3 h at 37 °C. The sample absorbance was measured at 570 nm with a 
reference wavelength of 630 nm by an ELISA reader (Bio-Tek Instrument, USA). 
 
Melanin inhibition assay 
 
B16 cells were seeded at a density of 2 ×10⁵cells/well. After 24 h, the cells were treated with CMRG (10-100 
µg/mL) or Re (10-100 µM) in the presence of 100 nM α-MSH to stimulate melanin production for 72 h. Then, the treated 
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cells were washed with PBS and harvested by trypsinization. Cell pellet was solubilized in 300 μL of 1 N NaOH containing 
10 % DMSO at 80°C for 1 h.  The relative melanin content was determined by measuring the absorbance at 475 nm by an 
ELISA reader (Lim et al., 2009). A standard curve for synthetic melanin (0–500 µg/mL) was prepared for each experiment. 
For melanin content analysis, arbutin was maintained as reference standard.  
 
Tyrosinase inhibition assay 
 
The tyrosinase activity was assayed using DOPA oxidase assay previously enunciated (Huang et al., 2013). 
Arbutin was used as reference standard. B16 cells were seeded at a density of 4 ×10⁵ cells/well in six-well plates. After 24 
h, the cells were treated with CMRG (10-100 µg/mL) or Re (10-100 µM) in the presence of 100 nM α-MSH for 72 h. Then, 
cells were washed with PBS, harvested by trypsinization and lysed with phosphate buffer (pH 6.9) containing 1 % Triton 
X-100. Following freeze-thawing at -80 °C for 15 min and storing at room temperature for 10 min, the samples were 
clarified by centrifugation at 12,000 × g for a period of 15 min at 4 °C. After centrifugation, 10 µL of freshly prepared 
substrate solution (15 mM L-DOPA in 48 mM pH 7.1 sodium phosphate buffer) was added to 90 µL of lysate supernatant 
and incubated at a 37 °C for 1 h. The absorbance was then measured at 475 nm using an ELISA reader.  
 
Reverse transcription polymerase chain reaction (RT-PCR) analysis and quantitative PCR analysis 
 
Total RNA was extracted using Trizol reagents solution (Sigma, MO, USA).  Reverse transcription and cDNA 
amplification were carried with 2 μg of total RNA using Thermo Scientific cDNA synthesis kit (Onebio, LT, EU) 
according to the manufacturer’s instructions. The cDNA obtained was amplified with the following primers: MITF forward 
5'- CGGGATGCCTTGTTTA TGGT-3' and reverse 5'TGCCTCTGAGCTTGCTGTAT-3', tyrosinase forward 5'-
ATGGGTCAA CACCCATGTTT-3' and reverse 5'-GGCAAATCCTTC CAGTGTGT-3', TRP-1 forward 5'- GTA 
CTGGTGAGCAGCTCTGT-3' and reverse 5'- CCAG GCTTCTCGGTCATCTT-3', TRP-2 forward 
5'CTTGGCTCACTCCTTCCTGA-3' and reverse 5'TTGCTCTGCGGTTAGGAAGA-3'. The reaction was cycled 25 times 
for 30 s at 95 °C, 30 s at 58 °C and 60 s at 72 °C for tyrosinase, MITF and TIRP-1 and cycled 25 times for 40 s at 94 °C, 40 
s at 60 °C and 90 s at 72 °C for TIRP-2.  The amplified RT-PCR products were analyzed on 0.8 % agarose gels, visualized 
by ethidium bromide staining and photographed under ultraviolet light. The quantitative real-time PCR was performed 
using an R-Corbett Rotor-Gene Model 6000 (Mortlake, Australia), with SYBR Green qPCR Super Mix UDG kit 
(Invitrogen, CA, USA). The relative expression levels of the target genes against the reference gene (GAPDH) were 
calculated using the delta cycle threshold (Ct) method (Schefe et al., 2006).  
 
Ligand Preparation  
 
Ginsenoside Re was selected as ligand molecule in our study and its 2D structure was obtained from our own 
Panax ginseng saponins database. Next, the 2D structure was converted to 3D structure using Discovery Studio 3.5 
visualizer. Arbutin structure was obtained from the PubChem compound online data base. All atomic coordinates of the 
downloaded structure were converted to .pdb format using free on line OpenBabel software (Geldenhuys et al., 2006). 
 
Protein preparation and molecular docking study 
  
The 3D structure of tyrosinase from Agaricus bisporus (PDB ID: 2Y9X) was retrieved from protein data bank. 
Chimera program was used to modify 2Y9X, as by deleting solvent, adding charge, and replacing an incomplete side chain. 
(Mu et al., 2013). In this study, we used arbutin as control drug. Finally, molecular docking study was performed with 
Autodock Vina. 
 
ADMET and PASS descriptors prediction 
 
The ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties of Re were determined as 
described previously (Sathishkumar et al., 2013). Pharmacological properties such as solubility level, serum protein 
binding, skin permeability, CYP2D6 inhibition probability, octanol/water partition coefficient were measured. Considering 
toxicity prediction as an important task in natural product research, we also predicted hepatotoxicity descriptors for 
ginsenoside Re using ADMET module accessible from discovery studio program (DS 3.5). The computational program 
PASS (Prediction of Activity Spectra for Substances) was used for predicting possible biological activity based on chemical 
structure (Lagunin et al., 2010). This method produced a list of biological activities from the ginsenoside Re structure, 
along with probability of activity (Pa) and probability of inactivity (Pi). 
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Statistical analysis 
 
All data are presented as mean ± standard deviation (S.D.). All experiments were independently performed thrice. 
Statistical analysis of the data was performed using ANOVA test.  Statistical significance was assigned at p < 0.05. 
 
Results 
Detection of ginseng saponins using high performance liquid chromatography analysis 
 
The ginsenosides content of CMRG was determined by HPLC. The HPLC profile of the CRMG extract revealed 
that ginsenosides Re, Rb1, Rg1, Rc and Rb2 to be the predominant saponins (Table 1). Ginsenoside Re was found to be the 
most abundant ginsenoside in the CRMG with a quantity of 15.22 mg/g. 
 Table 1. Content of ginsenosides in CRMG extract 
                                                               
 Effect of CRMG extract and ginsenoside Re on the growth and viability of B16 cells 
 
The CMRG extract did not have cytotoxic effect on B16 cells at concentrations ≤ 100 µg/mL, however cells 
treated with higher concentration of CRMG significantly decreased cell viability (IC50 = 672.17 µg/mL).  Similarly, 
ginsenoside Re showed no significant cytotoxicity at concentrations ≤100 μM but was shown to be toxic at 300 μM. To 
determine whether CMRG extract and Re were toxic to normal cells, HDF cells were treated with CRMG extract and Re 
with the same concentrations (Fig. 1A and B). CRMG extract affected the viability of HDF cells at concentrations higher 
than 500 µg/mL. However, HDF cell viability was not affected after treatment with 300 μM of Re.  
Therefore, further experiments were carried out at concentration ranging 0-100 µg/mL of CRMG and 0-100 μM of 
Re.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:  Cell viability of B16 and HDF cells after treatment with CRMG (A) and ginsenoside Re (B) in B16 and HDF 
cells. Results are reported as a percentage of sample-treated control and presented as mean ± SD of three different 
experiments. *P ＜ 0.05 and **P ＜ 0.01, ***P ＜ 0.001 vs. control. 
 
Measurement of melanin content and tyrosinase activity inhibition 
 
 Figure 2A and 2B show the inhibition effect on melanogenesis in B16 cells stimulated with α-MSH and after 72 h 
treatment with CMRG extract and Re. B16 cells treated with 100 nM of α-MSH significantly increased melanin production 
as opposed to B16 control cell. In addition, CRMG and Re led to a dose-dependent decrease in melanin production in α-
MSH stimulated cells. B16 cells treated with 100 µg/mL of CRMG showed a comparable inhibition to those treated with 
same concentration of arbutin. However, B16 cells treated with 100 μM of ginsenoside Re showed significant inhibition 
(***p < 0.001) compared to that treated with same concentration of arbutin. Cellular tyrosinase activity was significantly 
increased in B16 cells treated with α-MSH alone compared to control cells (Fig. 3A and 3B). CRMG and Re also 
Ginsenoside Rg1 Re Rf Rh1 Rg2 Rb1 Rc Rb2 Rd Ck Rh2  
mg/g 1.37 15.22 0.13 0.14 0.29 3.72 1.35 1.14 0.41 0.44 0.22  
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suppressed tyrosinase in dose dependent manner. Treatments were more effective than arbutin in concentrations >100 
µg/mL of CRMG and >100 μM of ginsenoside Re.  
Figure 2:  Effect on melanin content of CRMG (A) and Re (B). Results are reported as a percentage of α-MSH – treated 
control and presented as mean ± SD of three different experiments.  *P ＜ 0.05, **P ＜ 0.01, ***P ＜ 0.001 vs. α-MSH-
treated control. 
 
Figure 3:  Effect on tyrosinase inhibition activity of CRMG (A) and Re (B). Results are reported as a percentage of α-MSH 
– treated control and presented as mean ± SD of three different experiments.  *P ＜ 0.05, **P ＜ 0.01, ***P ＜ 0.001 vs. α-
MSH-treated control. 
 
RT-PCR analysis 
 
The α-MSH treatment increased tyrosinase family mRNA expression and its expression could be inhibited in a 
dose dependent manner by Re (Fig. 4A). B16 cells treated with indicated concentration of Re (50 - 100 µM) significantly 
inhibited mRNA expression levels of MITF, tyrosinase, TRP-1 and TRP-2 genes at higher level compared to those cells 
treated with 100 µM of arbutin (Fig. 4B to 4E). Thus, these results suggested that Re decreased mRNA expression of 
tyrosinase family leads to suppression of melanogenesis. 
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Figure 4: Effect of Re on the mRNA expression of melanogenesis-related genes (A). mRNA expression was visualized by 
RT-PCR. The sizes of amplified gene products were 528 bp for β-actin, 216 bp for MITF (B), 563 bp for tyrosinase (C), 
375 bp for TRP-1 (D) and 240 bp for DCT (E). Results are reported as a percentage of α-MSH – treated control and 
presented as mean ± SD of three different experiments.  *P ＜ 0.05, **P ＜ 0.01, ***P ＜ 0.001 vs. α-MSH-treated control 
and ###P ＜ 0.001 vs.  assay control. 
 
Molecular Docking Study 
 
The main purpose of molecular docking study was to predict the potential binding of Re to mushroom tyrosine 
through its binding affinity with specific active site of the selected protein (Table 2). The molecular docking result showed 
that ginsenoside Re interacted with mushroom tyrosinase residues ASN 81, ASN 260, ARG268, ALA323, and TYR65 
(Fig. 5A, B) with a binding affinity of -8.4 kcal/mol. In case of Arbutin, His 244 and ASN 260 residues of mushroom 
tyrosinase was predicted as the hydrogen bonding interactions (Fig. 5C, D), with binding affinity of -6.4 kcal/mol. 
 
Table 2. Molecular interaction results of Mushroom Tyrosinase (PDBID 2w9x) with ginsenoside Re and Arbutin, binding 
affinity values with key residues. 
No.  Compounds H-Bonding 
interactions 
Amino acid 
involved in 
interaction 
Docking 
Energy 
(kcal/mol) 
H-bond 
distance (Å) 
  Ligand Protein    
1 Arbutin O--- 
O--- 
---HE2 
---OD1 
HIS244 
ASN260 
-6.4 2.48349 
3.19587 
2 Ginsenoside 
Re 
HH--- 
O--- 
O--- 
O--- 
O--- 
---OD1 
--HH12 
---OD1 
---OH 
---O 
ASN81 
ARG268 
ASN260 
TYR65 
ALA323 
-8.4 2.31153 
2.19575 
2.46082 
3.07871 
3.06033 
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Figure 5: Predicted structure of Agaricus bisporus containing the binuclear copper binding active site (PDB ID 2Y9X). 
Docking of ginsenoside Re into the active site of mushroom tyrosinase (A- B). Docking of arbutin into the active site of 
mushroom tyrosinase (C-D). 
 
ADMET and PASS analysis of ginsenoside Re 
 
The results of predicted ADMET values of ginsenoside Re with acceptable range were described in Table 3. In 
addition, PASS analysis results indicated that ginsenoside Re supported the probability of active Pa > 0.8 as a 
anticarcinogenic, immunostimulant, antioxidant, transcription factor inhibitor, G-protein-coupled receptor kinase inhibitor, 
anti-inflammatory, transcription factor inhibitor, dermatologic, oxidoreductase inhibitor and wound healing agent all 
directly or indirectly related to melanogenesis.  
 
Table 3. ADMET results of selected ginsenoside Re with pharcokinetic properties 
 
Ginsenosid
e 
Solubilit
y Level 
Serum 
protein 
bindin
g 
Skin 
Permeabilit
y 
CYP2D6 
inhibitio
n 
Hepatotoxicit
y 
Qlog 
Po/w 
Lipinski 
rule of 5 
violation
s 
Jorgense
n rule of 
3 
violations 
Re -2.623 -1.339 -6.383 0.227 0 -
1.00
8 
3 2 
Acceptable  
range 
(-6.5-0.5) (-1.5-
1.5) 
(Kp in 
cm/hr) 
0 is Non-
inhibitor 
and 1 is 
inhibitor 
0 is non-toxic 
and 1 is toxic 
(-0.2 
to 
6.5) 
Maximu
m is 4 
Maximum 
is 3 
 
Discussion  
   
The cultured root of mountain ginseng extract and ginsenoside Re were analyzed for their effect on melanogenesis 
in α-MSH-treated B16 melanoma cells lines.  Firstly, we evaluated the cytotoxicity of CRMG and Re on the growth and 
viability of melanoma B16 cells and normal HDF cells using MTT assay method. As shown in figure 1A-B, CRMG and Re 
has no significant cytotoxic effect at 100 µg/mL and 100 µM respectively. Results indicate that inhibition of melanogenesis 
by CMRG extract and Re in B16 cells at mentioned concentrations could be attributed to their ability to inhibit tyrosinase  
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activity rather than to their cytotoxic effects. On the other hand, at higher concentrations CRMG extract and Re were toxic 
to the normal cells. However, CRMG and Re preferentially inhibited B16 melanoma cells growth. It suggested that CRMG 
and Re may possess potential anti melanoma activities. Previous studies have reported that mountain ginseng and Re have 
anti-cancer activity (Oh et al., 2006; Chen et al., 2016) although further studies have yet to be made to confirm this 
hypothesis.  
Application of α-MSH to B16 cells promotes activation of pre-existing molecules of tyrosinase in the cells by 
elevating cyclic AMP levels leading to the increase in production of melanin (LEE et al., 1972; Pawelek, 1976). CRMG 
and ginsenoside Re decreased tyrosinase activity and down-regulated cellular melanin synthesis in B16 cells in a 
concentration-dependent manner (Fig. 2 and Fig. 3). Ginseng root extracts are rich in phenolic compounds which are 
capable to inhibit tyrosinase and melanin synthesis, while ginsenosides prevent intracellular increase in reactive oxygen 
species (Kim and Uyama, 2005; Hwang et al., 2006).  
Ginsenoside Re was found to be the most abundant ginsenoside in the CRMG (Table 1). This result is in 
accordance to a previously reported study by Kim et al. (2009). Ginsenoside Re is a panaxatriol saponin and is abundantly 
present in ginseng root and berries. Cho et al. reported that Re has anti-inflammatory and antioxidant effect (Cho et al., 
2006). Oxidative stress and inflammatory factors alter the redox state of cell membrane proteins and affect melanocyte 
homeostasis resulting in melanogenesis (Kim and Uyama, 2005).  To better understand the molecular mechanisms of Re-
induced inhibitory effect, we further examined the effect of Re on the mRNA expression level of melanogenic transcription 
genes. It has been reported that MITF down-regulation is related to the suppression of the cyclic AMP-dependent signaling 
pathway stimulated by α-MSH in melanoma cells (Huh et al., 2010).  However, in the current study, we did not evaluate the 
inhibitory activity of ginsenoside Re in the cyclic AMP-mediated melanin production. MITF is regarded to be a key 
regulator of melanogenic markers including TRP-1 and TRP-2 expression, and consequently play an essential role in 
hypopigmentation as well as melanogenesis. As shown in Fig. 4A-E, Re significantly decreased mRNA expression levels 
of MITF, tyrosinase, TRP-1 and TRP-2 melanogenic genes. Our results showed that the mRNA expressions of MITF, 
tyrosinase, TRP-1 and TRP-2 were significantly enhanced in α-MSH-treated B16 melanoma cells. 
However, this α-MSH stimulatory effect was markedly down-regulated by Re in a dose-dependent manner 
compared to arbutin treatment. Thus, these results are in accordance with our hypothesis that ginsenoside Re decreases 
tyrosinase at the transcription level and consequently may reduce melanin content in B16 melanoma cells.  
In addition, to understand the mechanism of interaction between tyrosinase and ginsenoside Re and to find their 
binding energy, an in-silico docking study was performed. As given in supplementary Table 3, binding interaction of 
ginsenoside Re showed high activities and as well as selectivity for the inhibition of tyrosinase. In addition, the binding 
energies calculated by docking programs between tyrosinase and ginsenoside Re (-8.4 kcal/mol) were higher than to that of 
arbutin (-6.4 kcal/mol). This result implies that ginsenoside Re interacts more strongly with tyrosinase compared to arbutin. 
According to the docking analysis, the binding residues interacting with ginsenoside Re were ASN81, ARG268, ASN260, 
TYR65 and ALA323. These residues could have a key function and effect on the binding affinity with Re. Therefore, 
ginsenoside Re could inhibit tyrosinase activity by binding the active site of mushroom tyrosinase. Moreover, the ADMET 
and PASS results showed that ginsenoside Re was non-toxic and showed significant predicted biological activities. Taken 
together, these results suggested that ginsenoside Re can be used as anti-melanogenic agent.  
 
Conclusion 
 
Our result indicated that CRMG and Re inhibited melanin content in B16BL6 cell as well as inhibited tyrosinase 
activity. The anti-melanogenic effects of ginsenoside Re were mediated through the down-regulation of the expression 
levels of α-MSH-induced MITF and tyrosinase activity, as well as suppression of mRNA expression levels of 
melanogenesis factors such as TRP-1 and TRP-2 in B16BL6 melanoma cell line stimulated by α-MSH. These results 
suggested that CRMG extract and ginsenoside Re might be used as potential therapeutic agents in cosmetics for the 
inhibition of melanogenesis.  
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